The remaining 211 patients (57.5%) with persistent stroke symptoms and/or acute lesions in cerebral imaging were categorized as either receiving an acute therapeutic intervention for stroke (i.e. intravenous thrombolysis with recombinant tissue plasminogen activator (10.4%), mechanical thrombectomy (12.3%) or both (7.6%) or not receiving such an intervention. This evidence concerns the gene PLAT and stroke disorder.